- Home
- HUDI vs TPST Comparison
HUDI vs TPST Comparison
Compare HUDI & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUDI
- TPST
- Stock Information
- Founded
- HUDI 1998
- TPST 2011
- Country
- HUDI China
- TPST United States
- Employees
- HUDI N/A
- TPST N/A
- Industry
- HUDI Steel/Iron Ore
- TPST Biotechnology: Pharmaceutical Preparations
- Sector
- HUDI Industrials
- TPST Health Care
- Exchange
- HUDI Nasdaq
- TPST Nasdaq
- Market Cap
- HUDI 23.2M
- TPST 27.2M
- IPO Year
- HUDI 2021
- TPST N/A
- Fundamental
- Price
- HUDI $1.63
- TPST $0.71
- Analyst Decision
- HUDI
- TPST Strong Buy
- Analyst Count
- HUDI 0
- TPST 4
- Target Price
- HUDI N/A
- TPST $20.00
- AVG Volume (30 Days)
- HUDI 17.3K
- TPST 1.5M
- Earning Date
- HUDI 02-03-2025
- TPST 11-12-2024
- Dividend Yield
- HUDI N/A
- TPST N/A
- EPS Growth
- HUDI N/A
- TPST N/A
- EPS
- HUDI 0.18
- TPST N/A
- Revenue
- HUDI $83,462,634.00
- TPST N/A
- Revenue This Year
- HUDI N/A
- TPST N/A
- Revenue Next Year
- HUDI N/A
- TPST N/A
- P/E Ratio
- HUDI $8.84
- TPST N/A
- Revenue Growth
- HUDI 7.65
- TPST N/A
- 52 Week Low
- HUDI $1.55
- TPST $0.70
- 52 Week High
- HUDI $4.25
- TPST $6.00
- Technical
- Relative Strength Index (RSI)
- HUDI 28.94
- TPST 27.47
- Support Level
- HUDI $1.59
- TPST $0.86
- Resistance Level
- HUDI $1.72
- TPST $0.83
- Average True Range (ATR)
- HUDI 0.10
- TPST 0.07
- MACD
- HUDI -0.02
- TPST -0.01
- Stochastic Oscillator
- HUDI 14.68
- TPST 4.33
About HUDI Huadi International Group Co. Ltd.
Huadi International Group Co Ltd is a manufacturer of industrial stainless steel seamless pipes and tubes products. Its products are used in the oil & gas transmission, chemistry engineering, food processing, medical devices, aeronautics and astronautics, boiler, irrigation works construction, automobile and naval architecture, paper mill and mechanical industries. Products are exported to the United States, Mexico, Thailand, Australia, Argentina, Taiwan, India, the Philippines, UAE and Canada. Geographically, majority revenue is generated from China.
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.